---
$id: https://graph.org.ai/products/commodity/51201811
$type: Product
source: UNSPSC
code: "51201811"
title: "Thalidomide"
class: "51201800"
classTitle: "Immunostimulating agents"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Thalidomide

**UNSPSC Code**: 51201811
**Class**: [Immunostimulating agents](Immunostimulating agents.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an indole compound and immunosuppressant with the molecular formula C13H10N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4Z8R6ORS6L, chemically known as 2,6-dioxo-3-phthalimidopiperidine but generally known as thalidomide, which bears US NIH Compound Identifier 5426. European Medicines Agency schedules Thalidomide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10958MIG. The term THALIDOMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules thalidomide in its Anatomical Therapeutic Chemical (ATC) Classification. THALIDOMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule thalidomide under HS 29251995 and SITC 51482. As of Q4 2014, THALIDOMIDE remains the US FDA Preferred Term for this commodity. Thalidomide bears US NLM identifiers UMLS ID C0039736 and NCI Concept Code C870. SMILES: O=C1NC(=O)CCC1N1C(=O)C2C(C1=O)CCCC2.

